SCHEMBL2344362

SCHEMBL2344362

NC(=O)c1ccc(Br)cc1C(N)=O

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DGAT1 O75907 1/20 0.67
KDM4E B2RXH2 2/20 0.52
GLA P06280 1/20 0.52
CASP1 P29466 2/20 0.50
CES2 O00748 1/20 0.50
GALR3 O60755 1/20 0.50
CYP1A2 P05177 1/20 0.50
CYP2C9 P11712 1/20 0.50
HPGD P15428 1/20 0.50
ALOX15 P16050 1/20 0.50
CYP2C19 P33261 1/20 0.50
PLAU P00749 1/20 0.48
PARP1 P09874 1/20 0.48
MAPT P10636 3/20 0.46
POLB P06746 1/20 0.46
RXFP1 Q9HBX9 1/20 0.44
MYC P01106 1/20 0.43
NR4A1 P22736 1/20 0.43
ADRA1D P25100 1/20 0.42
GSTA1 P08263 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9450696 0.89 KDM4E (0.62) DGAT1KDM4EGLACASP1CES2
SCHEMBL9450697 0.89 KDM4E (0.62) DGAT1KDM4EGLACASP1CES2
SCHEMBL2853526 0.84 DGAT1 (0.59) DGAT1KDM4EGLACASP1CES2
SCHEMBL29435112 0.84 DGAT1 (0.59) DGAT1KDM4EGLACASP1CES2
SCHEMBL20808925 0.84 DGAT1 (0.64) DGAT1KDM4EGLACASP1CES2
SCHEMBL3488897 0.82 ALDH1A1 (0.62) DGAT1KDM4EGLACASP1CES2
SCHEMBL7370270 0.82 DGAT1 (0.53) DGAT1KDM4EGLACASP1HPGD
SCHEMBL1175614 0.82 HPGD (0.69) DGAT1KDM4EGLACASP1CES2
SCHEMBL13740129 0.82 DGAT1 (0.62) DGAT1KDM4EGLACASP1CES2
SCHEMBL5759947 0.82 DGAT1 (0.57) DGAT1KDM4EGLACASP1CES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2206749-B1 PHTHALOCYANINE COMPOUND NISSAN CHEMICAL IND LTD (JP) 2012-11-21 EP disclosed
EP-2206749-B1 PHTHALOCYANINE COMPOUND NISSAN CHEMICAL IND LTD (JP) 2012-11-21 EP disclosed
US-8304536-B2 Phthalocyanine compound NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2012-11-06 US disclosed
US-8304536-B2 Phthalocyanine compound NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2012-11-06 US disclosed
CN-102216321-A Therapeutic antiviral peptides INTERMUNE INC 2011-10-12 CN disclosed
EP-2358736-A1 THERAPEUTIC ANTIVIRAL PEPTIDES Intermune, Inc. (US) 2011-08-24 EP disclosed
US-20100228021-A1 PHTHALOCYANINE COMPOUND NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2010-09-09 US disclosed
US-20100228021-A1 PHTHALOCYANINE COMPOUND NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2010-09-09 US disclosed
EP-2206749-A1 PHTHALOCYANINE COMPOUND Nissan Chemical Industries, Ltd. (JP) 2010-07-14 EP disclosed
EP-2206749-A1 PHTHALOCYANINE COMPOUND Nissan Chemical Industries, Ltd. (JP) 2010-07-14 EP disclosed
US-20100119479-A1 THERAPEUTIC ANTIVIRAL PEPTIDES INTERMUNE, INC. (US) 2010-05-13 US disclosed
WO-2010045266-A1 THERAPEUTIC ANTIVIRAL PEPTIDES INTERMUNE, INC. (US) 2010-04-22 WO disclosed
JP-2003026646-A METHOD OF PRODUCING 4-BROMOPHTHALONITRILE SEIKO EPSON CORP 2003-01-29 JP disclosed
WO-1995027692-A1 SUBTITUTED BIPHENYL TNF INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 1995-10-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100119479-A1 THERAPEUTIC ANTIVIRAL PEPTIDES SARS1, VIP, MAVS DGAT1 3602/4885KDM4E 4649/4885GLA 2660/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.